Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT03680144
NA

Utility of Perfusion MRI to Detect Radiation Necrosis in Patients With Brain Metastases

Sponsor: Emory University

View on ClinicalTrials.gov

Summary

This trial studies how well dynamic susceptibility contrast-magnetic resonance imaging (MRI) works in determining radiation necrosis and tumor progression in participants with cancer that has spread to the brain and are being treated with radiation therapy. Diagnostic procedures, such as dynamic susceptibility contrast-MRI, may improve the ability to determine indeterminate post-treatment changes seen on imaging after radiation therapy.

Official title: Diagnostic Accuracy of Dynamic Susceptibility Contrast (DSC) Perfusion MRI to Determine Radiation Necrosis Versus Tumor Progression in Brain Metastases Treated With Stereotactic Radiosurgery

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

8

Start Date

2018-11-28

Completion Date

2021-06-15

Last Updated

2026-04-24

Healthy Volunteers

No

Interventions

PROCEDURE

Dynamic Susceptibility Contrast-MRI (DSC-MRI)

Undergo DSC-MRI

PROCEDURE

Magnetic Resonance Imaging (MRI)

Undergo diagnostic MRI

Locations (2)

Emory University Hospital/Winship Cancer Institute

Atlanta, Georgia, United States

Emory Saint Joseph's Hospital

Atlanta, Georgia, United States